Multicenter Evaluation of Patients with Cutaneous Malignant Melanoma in Turkey: MELAS Study

Basit Öğe Kaydı
dc.contributor.authorSönmez, Özlem Uysal
dc.contributor.authorTanrıverdi, Özgür
dc.contributor.authorEşbah, Onur
dc.contributor.authorÜyetürk, Ümmügül
dc.contributor.authorHelvacı, Kaan
dc.contributor.authorBal, Öznur
dc.contributor.authorÖksüzoğlu, Berna
dc.date.accessioned2020-04-30T23:19:23Z
dc.date.available2020-04-30T23:19:23Z
dc.date.issued2013
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionWOS: 000319980200095en_US
dc.descriptionPubMed: 23534790en_US
dc.description.abstractBackground: Malignant melanoma is a cancer that demonstrates rapid progression and atypical clinically features with a poor prognosis. Aim: This study was performed to determine the clinical characteristics and treatment outcomes of patients with malignant melanoma in Turkey. Methods: The medical records of 98 patients between 2007-2012 at our centers were retrieved from the patient registry. Overall survival (OS) was calculated using the Kaplan-Meier method. Results: In our study, with the median follow-up of all patients with cutaneous MM of 46.3 months, the median OS rate of all cases was 43.6 months and 5-year OS was 48.6%. However, five-year OS rates of patients with localized disease (stage I-II) and node involvement (stage III) were 60.3% and 39.6%, respectively. The median OS of stage IV patients was 8.7 months and 1-year OS rate was 26.2%. We showed that advanced stage, male gender, and advanced age in all patients with MM were significant prognostic factors of OS. Conclusions: Compared with the results of current studies from Western countries, we found similar findings concerning demographical features, histological variables and survival analyses for our patients with cutaneous MM in Turkey.en_US
dc.identifier.doi10.7314/APJCP.2013.14.1.533en_US
dc.identifier.endpage537en_US
dc.identifier.issn1513-7368
dc.identifier.issue1en_US
dc.identifier.startpage533en_US
dc.identifier.urihttps://doi.org/10.7314/APJCP.2013.14.1.533
dc.identifier.urihttps://hdl.handle.net/20.500.12684/3741
dc.identifier.volume14en_US
dc.identifier.wosWOS:000319980200095en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAsian Pacific Organization Cancer Preventionen_US
dc.relation.ispartofAsian Pacific Journal Of Cancer Preventionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCutaneous malignant melanomaen_US
dc.subjectsurvivalen_US
dc.subjectprognostic factorsen_US
dc.subjectTurkeyen_US
dc.titleMulticenter Evaluation of Patients with Cutaneous Malignant Melanoma in Turkey: MELAS Studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
3741.pdf
Boyut:
385.07 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu